1-4 of 4
Authors: Michael Wantman
Sort by
Journal Article
Low Frequency Nonnucleoside Reverse-Transcriptase Inhibitor—Resistant Variants Contribute to Failure of Efavirenz-Containing Regimens in Treatment-Experienced Patients
Get access
Elias K. Halvas and others
The Journal of Infectious Diseases, Volume 201, Issue 5, 1 March 2010, Pages 672–680, https://doi.org/10.1086/650542
Published: 01 March 2010
Journal Article
A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug-Resistant HIV: 48-Week Virologic Results of ACTG A5086
Get access
Constance A. Benson and others
The Journal of Infectious Diseases, Volume 194, Issue 9, 1 November 2006, Pages 1309–1318, https://doi.org/10.1086/508289
Published: 01 November 2006
Journal Article
Detection of Drug-Resistant Minority Variants of HIV-1 During Virologic Failure of Indinavir, Lamivudine, and Zidovudine
Get access
Carrie Dykes and others
The Journal of Infectious Diseases, Volume 189, Issue 6, 15 March 2004, Pages 1091–1096, https://doi.org/10.1086/382033
Published: 15 March 2004
Journal Article
Analysis of Human Immunodeficiency Virus Type 1 Drug Resistance in Children Receiving Nucleoside Analogue Reverse-Transcriptase Inhibitors plus Nevirapine, Nelfinavir, or Ritonavir (Pediatric AIDS Clinical Trials Group 377)
Get access
Susan H. Eshleman and others
The Journal of Infectious Diseases, Volume 183, Issue 12, 15 June 2001, Pages 1732–1738, https://doi.org/10.1086/320728
Published: 15 June 2001
Advertisement
Advertisement